Metformin
ZITUVIMET is a combination of sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, and metformin hydrochloride (HCl), a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
United States
$2
per month
India
$0
per month
You save
−93%save $2/mo · 93% cheaper
34.4M US scripts/yr$53.6M potential annual savings$57.8M US spend/yr
Drag to rotate · 3D structureC4H11N5
SMILES: CN(C)C(=N)N=C(N)N
Compare the price
US price$2per month
India price$0per month
You save$293% less
Based on 30 units per month. US $0.06 vs India $0.00 per unit.
Total over 1 periodSave $2$2 → $0
The bigger picture
Metformin is filled about 34.4M times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$57.8M
If sourced from India
$4.1M
Potential annual savings
$53.6M
−93%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.